Table2_YinChen WuLing powder attenuates non-alcoholic steatohepatitis through the inhibition of the SHP2/PI3K/NLRP3 pathway.xlsx

Table2_YinChen WuLing powder attenuates non-alcoholic steatohepatitis through the inhibition of the SHP2/PI3K/NLRP3 pathway.xlsx

Background<p>YinChen WuLing Powder (YCWLP) has been recommended by consensus for the treatment of non-alcoholic steatohepatitis (NASH); nevertheless, its specific pharmacological mechanisms remain to be elucidated. This study aims to dissect the mechanisms underlying the therapeutic effects of...

Full description

Saved in:
Bibliographic Details
Main Author: Xingxing Yuan (6615878) (author)
Other Authors: Liuxin Yang (8442297) (author), Tinting Gao (19176847) (author), Jiawei Gao (11758514) (author), Bingyu Wang (8044910) (author), Chengxiang Liu (5370086) (author), Wei Yuan (64653) (author)
Published: 2024
Subjects:
Pharmacology
Basic Pharmacology
Clinical Pharmacology and Therapeutics
Clinical Pharmacy and Pharmacy Practice
Pharmaceutical Sciences
Pharmacogenomics
Toxicology (incl. Clinical Toxicology)
Pharmacology and Pharmaceutical Sciences not elsewhere classified
YinChen WuLing powder
network pharmacology
molecular docking
in vitro validation
SHP2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items